All In Biotech

Drug Trial Radar · NCT03279302

Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

A Phase 1, Open-Label, Partially Randomized, 3-Part, Parallel Group Trial to Evaluate the Pharmacokinetic Profile of Glepaglutide (ZP1848) After a Single Intravenous Injection and After Multiple Subcutaneous Injections in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Dec 22, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

75

Actual

Start

Sep 4, 2017

Primary completion

Dec 18, 2017

Study completion Dec 18, 2017

Sponsor

Lead sponsor
Zealand PharmaIndustry
Sponsor type
Industry
First posted
Sep 12, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of the trial is to characterize the pharmacokinetic (PK) profiles of glepaglutide and its primary active metabolites following once-daily and once-weekly subcutaneous (SC) injections and after a single intravenous (IV) infusion in healthy subjects. Glepaglutide is a proposed International Nonproprietary Name for ZP1848

Conditions

  • Healthy Subjects

Interventions

  • GlepaglutideDrug

    Solution for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetic parameter - half lifeTime frame: Day 0 up to Day 73
  2. Pharmacokinetic parameter - total body clearanceTime frame: Day 0 to Day 22
  3. Pharmacokinetic parameter - Apparent clearanceTime frame: Day 0 to Day 73
  4. Pharmacokinetic parameter - Volume of distributionTime frame: Day 0- Day 22
  5. Pharmacokinetic parameter - apparent volume of distributionTime frame: Day 0 to Day 73

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Covance CRU

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.